Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer’s disease agents
Authors:
- Hongwei GaoHGHongwei Gao
- Yingying JiangYJYingying Jiang
- Jiuyu ZhanJZJiuyu Zhan
- Yingni SunYSYingni Sun
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 114
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Acetyl and butyryl cholinesterase inhibitory sesquiterpene lactones from Amberboa ramosaBMC Chemistry, 2013
- Identification of potential bivalent inhibitors from natural compounds for acetylcholinesterase through in silico screening using multiple pharmacophoresJournal of Molecular Graphics and Modelling, 2013
- Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's diseaseMedicinal Research Reviews, 2011
- The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studiesJournal of Biomedical Science, 2011
- QSAR-based solubility model for drug-like compoundsBioorganic & Medicinal Chemistry, 2010
- Pharmacophore modeling and applications in drug discovery: challenges and recent advancesDrug Discovery Today, 2010
- Virtual Screening Discovery of New Acetylcholinesterase Inhibitors Issued from CERMN Chemical LibraryJournal of Chemical Information and Modeling, 2010
- Alzheimer's diseaseThe Lancet, 2006
- The cholinergic hypothesis of Alzheimer's disease: a review of progressJournal of Neurology, Neurosurgery & Psychiatry, 1999
- The cholinergic hypothesis of Alzheimer's disease: a review of progressJournal of Neurology, Neurosurgery & Psychiatry, 1999